Cigna Corp. (CI) Misses Q4 EPS by 17c, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus

Cigna Corp. (NYSE: CI) reported Q4 EPS of $3.51, $0.17 worse than the analyst estimate of $3.68. Revenue for the quarter came in at $41.67 billion versus the consensus estimate of $39.99 billion.

"I'm extremely proud of the ways in which our 70,000-plus Cigna employees delivered for our customers, our clients, our providers, our partners, and our shareholders amid the ongoing COVID-19 pandemic," said David M. Cordani, president and chief executive officer. "Our fourth quarter results were in line with expectations, as we continued to make investments in our customers, capabilities, and co-workers — all while covering elevated COVID-related costs. As a result, we have entered 2021 with great momentum, and our health services portfolio, fueled by the launch of Evernorth, is well-positioned for sustained long-term growth."

GUIDANCE:

Cigna Corp. sees FY2021 EPS of $20.00, versus the consensus of $20.59. Cigna Corp. sees FY2021 revenue of $165 billion, versus the consensus of $164.12 billion.

For earnings history and earnings-related data on Cigna Corp. (CI) click here.

You May Also Be Interested In

• Sanuwave Q2 2026 revenue tops revised guidance range
• Eupraxia Pharmaceuticals adds executives, shifts operations to Vancouver
• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside